RESUMO
Narcolepsy-cataplexy is characterised by orexin deficiency, sleep disturbance, obesity and dysautonomia. Ghrelin and obestatin affect both energy intake and sleep. Our aim was to investigate ghrelin, obestatin and metabolic/autonomic function in narcolepsy-cataplexy. Eight narcolepsy-cataplexy patients (seven CSF orexin-deficient) and eight matched controls were studied. The subjects had a fixed energy meal with serial blood samples and measurement of heart rate variability (HRV). Fasting plasma obestatin was more than threefold higher in narcolepsy subjects (narcolepsy 89.6 ± 16 pg/ml vs. control 24.9 ± 3 pg/ml, p < 0.001). There was no change in HRV total power, but post-prandial low-frequency (LF) power and high-frequency (HF) power were lower in the narcolepsy group [area under the curve (AUC): HF power narcolepsy 1.4 × 10(5) ± 0.2 × 10(5) vs. control 3.3 × 10(5) ± 0.6 × 10(5 )ms(2)/h, p < 0.001]. On multiple regression analyses, the only significant predictor of plasma obestatin was HF power, which was inversely correlated with obestatin (ß = -0.65 R (2) = 38 %, p = 0.009). Fasting and post-prandial plasma ghrelin were similar in both groups (narcolepsy 589.5 ± 88 pg/ml vs. control 686.9 ± 81 pg/ml, p = 0.5; post-prandial AUC-narcolepsy 161.3 ± 22 ng/ml/min vs. control 188.6 ± 62 ng/ml/min, p = 0.4). Only the narcolepsy group had significant suppression of plasma ghrelin after the meal (ANOVA, p = 0.004). In orexin-deficient narcolepsy, fasting plasma ghrelin is unaltered, and post-prandial suppression is preserved. Fasting plasma obestatin is increased and correlates with autonomic dysfunction. As obestatin affects NREM sleep, we suggest that increased plasma levels contribute to the disrupted sleep-state control in narcolepsy.
Assuntos
Sistema Nervoso Autônomo/fisiopatologia , Grelina/sangue , Peptídeos e Proteínas de Sinalização Intracelular/deficiência , Narcolepsia/sangue , Neuropeptídeos/deficiência , Adulto , Jejum/sangue , Feminino , Humanos , Peptídeos e Proteínas de Sinalização Intracelular/sangue , Masculino , Pessoa de Meia-Idade , Narcolepsia/fisiopatologia , Neuropeptídeos/sangue , Orexinas , Período Pós-PrandialAssuntos
Diabetes Mellitus Tipo 2/tratamento farmacológico , Obesidade/tratamento farmacológico , Receptores de Glucagon/agonistas , Receptores de Glucagon/metabolismo , Criança , Diabetes Mellitus Tipo 2/metabolismo , Exenatida , Feminino , Receptor do Peptídeo Semelhante ao Glucagon 1 , Humanos , Obesidade/metabolismo , Peptídeos/uso terapêutico , Peçonhas/uso terapêuticoRESUMO
BACKGROUND: Identifying patients who need Nursing Home (NH) care following a hospital admission is important. OBJECTIVE: To identify the factors that predispose to an NH discharge. DESIGN: Prospective observational study with blinded end-point evaluation. SETTING: A non-acute geriatric hospital. SUBJECTS: Two hundred consecutive elderly patients who were admitted for rehabilitation following treatment for an acute illness. MAIN OUTCOME MEASURES: Discharge to an NH or home. RESULTS: Thirty-five out of the 150 live discharges (23.3%) were to an NH. NH discharges had a longer length of stay (38.5 versus 19.8 days; p < 0001). They were more likely to have visual impairment (p = 0.0009), confusion (p < 0.0001), wandering behaviour (p = 0.003), incontinence (p < 0.0001 or unsafe gait (p = 0.0005), to be on tranquillizers (p = 0.003), to be at risk of falls (p = 0.02) and to have sustained a fall while in hospital (p = 0.001). Multiple logistic regression identified confusion (p = 0.001), incontinence (p = 0.02), falls in hospital (p = 0.01), gait abnormalities (p < 0.001), tranquillizers (p < 0.001), impaired distant vision (p = 0.01) and living alone (p < 0.001) as independently associated with the risk of an NH discharge. This risk proportionately increased with the number of risk factors present: 4.28% for 0-2 factors, 25.8% for 3-4 factors and 81.8% for 5-6 factors (p < 0.0001). CONCLUSION: These factors should be the target of specific rehabilitation in an attempt to reduce the risk of discharge to a nursing home and improve patient outcome.